Protein Sciences Segment News Today

MINNEAPOLIS, May 22, 2024 /PRNewswire/ -- Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2024. Third Quarter FY2024...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at...

Bio-Techne Corporation today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:45 a.m. EDT.

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life...

MINNEAPOLIS, Feb. 1, 2024 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the second quarter ended December 31, 2023. Second Quarter FY2024 Highlights Second quarter...

MINNEAPOLIS, Dec. 21, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Kim Kelderman, current Chief Operating Officer, and Chief Executive Officer effective February 1, 2024, will...

MINNEAPOLIS, Nov. 27, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Chuck Kummeth, President and Chief Executive Officer, and Kim Kelderman, Chief Operating Officer will present...

MINNEAPOLIS, Oct. 31, 2023 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the first quarter ended September 30, 2023. First Quarter FY2024 Highlights First quarter...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) was pleased to host presentations by three industry experts yesterday at the CASSS CE Pharm conference in...